Inventor · disambiguated record
George Thomas
Also filed as: THOMAS GEORGE · THOMAS GEORGE V
10 granted patents·9 pending applications·85 citations·filing 1992–2021
86Inventor score
Top patents by PatentIndex Score
19 records- 0187US5342846A7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agentsSYNPHAR LAB INC·Filed 1992·Granted Aug 30, 1994·52 cites·68 claims
- 0274US6635621B1Cysteine protease inhibitorsNAEJA PHARMACEUTICAL INC·Filed 2000·Granted Oct 21, 2003·10 cites·11 claims
- 0373US7749698B2p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agentNOVARTIS AG·Filed 2005·Granted Jul 6, 2010·1 cites·5 claims
- 0465US6916803B23-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agentsPANTHERIX LTD·Filed 2001·Granted Jul 12, 2005·4 cites·19 claims
- 0563US6833255B1Drosophila melanogaster p70 S6 kinaseNOVARTIS AG·Filed 2003·Granted Dec 21, 2004·9 cites·2 claims
- 0663US6534311B2Drosophila melanogaster p70S6 kinaseNOVARTIS AG·Filed 2001·Granted Mar 18, 2003·9 cites·8 claims
- 0763US2021236500A1Inhibition of autophagy using phospholipase a2 inhibitorsUNIV OREGON HEALTH & SCIENCE·Filed 2021·Application pending·0 cites
- 0860US2019142835A1Inhibition of autophagy using phospholipase a2 inhibitorsUNIV OREGON HEALTH & SCIENCE·Filed 2018·Application pending·0 cites
- 0948US2008299589A1Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate CancersUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 1046US9261498B2Biomarker for sensitivity to mTOR inhibitor therapy in kidney cancerSAWYERS CHARLES L·Filed 2006·Granted Feb 16, 2016·0 cites·6 claims
- 1145US9279811B2Methods and kits that identify tumors responsive to Src inhibitorsTHOMAS GEORGE V·Filed 2013·Granted Mar 8, 2016·0 cites·8 claims
- 1242US2003166034A1P70-S6K or related kinase with constitutive activityFiled 2002·Application pending·0 cites
- 1341US2007191259A1Inhibition of s6 kinaze activity for the treatment of insulin resistanceAUWERX JOHAN·Filed 2004·Application pending·0 cites
- 1437US2004024000A1Dihydropyrimidine derivatives as cysteine protease inhibitorsFiled 2001·Application pending·0 cites
- 1536US2007053910A1Modulation of s6 kinase activity for the treatment of obesityFRIGERIO FRANCESCA·Filed 2003·Application pending·0 cites
- 1636US2005004068A1Modulation of torFiled 2002·Application pending·0 cites
- 1731US2016223557A1Method of isolating circulating tumor cellsTHOMAS GEORGE V·Filed 2016·Application pending·0 cites
- 1827US5994342A3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives useful as antitumor agentsTAIHO PHARMACEUTICAL CO LTD·Filed 1995·Granted Nov 30, 1999·0 cites·9 claims
- 1926US5652234A3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agentTAIHO PHARMACEUTICAL CO LIMITE·Filed 1995·Granted Jul 29, 1997·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when George Thomas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →